GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is a naturally occurring tripeptide that was first isolated from human plasma in the early 1970s. It has since become one of the most studied peptides in both skin science and longevity research, with a breadth of biological activity that makes it uniquely relevant at the intersection of aesthetic medicine and anti-aging biology.
What GHK-Cu Does in the Body
GHK-Cu is not a synthetic construct. It is a fragment of the larger protein albumin that is naturally released in the body in response to tissue injury. Its biological functions include:
- Collagen synthesis activation: GHK-Cu stimulates fibroblasts to produce collagen types I and III, the primary structural proteins in skin, tendons, and connective tissue. It also promotes the production of glycosaminoglycans (hyaluronic acid, dermatan sulphate), which contribute to tissue hydration and volume.
- Anti-inflammatory activity: GHK-Cu strongly down-regulates inflammatory cytokines including TNF-alpha and IL-1, while upregulating anti-inflammatory signalling. This makes it relevant for conditions where chronic inflammation drives tissue degradation.
- Angiogenesis and wound healing: Like BPC-157, GHK-Cu promotes VEGF-driven angiogenesis and accelerates wound healing by stimulating fibroblast migration and proliferation.
- Antioxidant defence: GHK-Cu upregulates antioxidant enzymes (superoxide dismutase, catalase) and has direct copper-mediated antioxidant activity.
Plasma GHK levels are high in youth (approximately 200 ng/mL) and decline significantly with age (under 80 ng/mL by age 60), suggesting that GHK-Cu decline contributes to the age-related degradation of tissue repair capacity.
The Epigenetic Longevity Dimension
Beyond its established roles in wound healing and skin biology, research published by Lund Pickart (GHK-Cu's original discoverer) and subsequent groups has shown that GHK-Cu has broad epigenetic regulatory effects. Analysis of GHK-Cu's gene expression effects shows:
- It down-regulates genes associated with cancer, inflammation, and tissue degeneration
- It up-regulates genes associated with tissue repair, DNA stability, and metabolic health
- Its gene expression signature partially overlaps with longevity-associated gene expression patterns
This is not yet mechanistically explained at the level required for definitive clinical claims, but it provides biological plausibility for GHK-Cu's use in longevity contexts beyond skin health.
GHK-Cu for Skin: What the Evidence Shows
The skin science evidence for GHK-Cu is the most clinically developed of any application:
- Reduced wrinkle depth: Randomised controlled trials have shown topical GHK-Cu reduces fine lines and wrinkle depth after 12 weeks of daily use
- Improved skin density and thickness: GHK-Cu stimulates the dermal fibroblast activity needed to maintain skin structure
- Enhanced skin firmness: Collagen and glycosaminoglycan production driven by GHK-Cu improves skin firmness measurably
- Wound healing acceleration: GHK-Cu is used clinically in wound care for its fibroblast-activating and angiogenic effects
Topical GHK-Cu is available in cosmeceutical formulations at varying concentrations. Systemic GHK-Cu through peptide therapy is used when broader biological effects (beyond skin) are the goal.
Topical vs Systemic GHK-Cu
The choice between topical and systemic GHK-Cu depends on the treatment goal:
| Goal | Appropriate Route |
|---|---|
| Skin quality improvement (wrinkles, firmness, glow) | Topical, daily application |
| Wound healing or scar reduction (skin) | Topical, local application |
| Systemic anti-inflammatory and longevity effects | Systemic (injectable) |
| Combined skin and longevity goals | Both routes together |
Longegra's programs can include topical formulations alongside the broader longevity peptide protocol, allowing both local and systemic GHK-Cu activity.
GHK-Cu in the Context of a Longevity Protocol
GHK-Cu is typically included as one component of a broader longevity protocol rather than used in isolation. Complementary peptides include:
- GH secretagogues (CJC-1295, ipamorelin) for IGF-1-driven collagen and tissue repair
- Epitalon for telomere maintenance and circadian support
- Thymosin Alpha-1 for immune function
- BPC-157 when musculoskeletal repair is also a goal
Frequently Asked Questions (FAQs)
GHK-Cu is a naturally occurring tripeptide with an excellent safety profile in both topical and systemic forms. Long-term use at therapeutic concentrations has not shown adverse effects in the published literature. As with all peptides, physician assessment is appropriate before starting a systemic program.
